We are looking for Partners / Distributors in USA 🇺🇸 for our Private Ultra Encrypted Communication Network “EchoLink” — 50% Commission ($9,000 per sale). Click Here
Daily Short Volume USKRYS

KRYS Short Pressure Continues

Krystal Biotech (KRYS) has been flagged for 77 consecutive days on the FINRA threshold list, indicating persistent short-selling pressure.

By The Forensic Ledger Desk September 26, 20261 min read
Company
Krystal Biotech
Borrow Fee
0.3%
Short % Float
13.7%
Days to Cover
10.3

KRYS Threshold Flag Update

Krystal Biotech (KRYS) continues to face significant short-selling pressure, remaining on the FINRA Reg SHO threshold list for 77 consecutive trading days. This sustained presence on the list is a strong signal of institutional short-selling activity that has not been resolved through standard settlement processes. With a borrow fee of 0.3% and short interest representing 13.7% of the float, the stock is currently under heavy scrutiny. The 10.3 days-to-cover ratio indicates that the short position is substantial relative to average daily trading volume, increasing the risk of a potential short squeeze if the stock price trends upward.

Source

Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#US Equities

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.